Rosse WF - Search Results

1

Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM.

Hughey CT, Brewer JW, Colosia AD, Rosse WF, Corley RB. Hughey CT, et al. Among authors: rosse wf. J Immunol. 1998 Oct 15;161(8):4091-7. J Immunol. 1998. PMID: 9780180

2

Distinct restriction of complement- and cell-mediated lysis.

Hollander N, Shin ML, Rosse WF, Springer TA. Hollander N, et al. Among authors: rosse wf. J Immunol. 1989 Jun 1;142(11):3913-6. J Immunol. 1989. PMID: 2785570

3

Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.

Coyne KE, Hall SE, Thompson S, Arce MA, Kinoshita T, Fujita T, Anstee DJ, Rosse W, Lublin DM. Coyne KE, et al. J Immunol. 1992 Nov 1;149(9):2906-13. J Immunol. 1992. PMID: 1383332

4

Comparison of binding characteristics of factors B and H to C3b on normal and paroxysmal nocturnal hemoglobinuria erythrocytes.

Parker CJ, Baker PJ, Rosse WF. Parker CJ, et al. Among authors: rosse wf. J Immunol. 1983 Nov;131(5):2484-9. J Immunol. 1983. PMID: 6226743

5

Differential susceptibility of type III erythrocytes of paroxysmal nocturnal hemoglobinuria to lysis mediated by complement and perforin.

Jiang S, Persechini PM, Rosse WF, Perussia B, Young JD. Jiang S, et al. Among authors: rosse wf. Biochem Biophys Res Commun. 1989 Jul 14;162(1):316-25. doi: 10.1016/0006-291x(89)91998-0. Biochem Biophys Res Commun. 1989. PMID: 2751655

6

The homologous restriction factor is immunologically related to complement components C8 and C9 and to lymphocyte pore-forming protein perforin through cysteine-rich domains.

Young JD, Rosse WF, Hasselkus-Light CS. Young JD, et al. Among authors: rosse wf. Biochem Biophys Res Commun. 1990 Jan 30;166(2):648-52. doi: 10.1016/0006-291x(90)90858-k. Biochem Biophys Res Commun. 1990. PMID: 2302230

7

Cold-reacting antibodies: the enhancement of antibody fixation by the first component of complement (C'1a).

Rosse WF, Borsos T, Rapp HJ. Rosse WF, et al. J Immunol. 1968 Feb;100(2):259-65. J Immunol. 1968. PMID: 4966454 No abstract available.

8

Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells.

Stafford HA, Tykocinski ML, Lublin DM, Holers VM, Rosse WF, Atkinson JP, Medof ME. Stafford HA, et al. Among authors: rosse wf. Proc Natl Acad Sci U S A. 1988 Feb;85(3):880-4. doi: 10.1073/pnas.85.3.880. Proc Natl Acad Sci U S A. 1988. PMID: 2448783 Free PMC article.

9

Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.

Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WF. Telen MJ, et al. Among authors: rosse wf. J Exp Med. 1988 Jun 1;167(6):1993-8. doi: 10.1084/jem.167.6.1993. J Exp Med. 1988. PMID: 2455016 Free PMC article.

10

Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.

Medof ME, Gottlieb A, Kinoshita T, Hall S, Silber R, Nussenzweig V, Rosse WF. Medof ME, et al. Among authors: rosse wf. J Clin Invest. 1987 Jul;80(1):165-74. doi: 10.1172/JCI113043. J Clin Invest. 1987. PMID: 2439544 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters